Asia-Pacific Cancer mTOR Inhibitors Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 112 pages | ID: AD93EF5E62FEN
99Strategy

Abstracts

SNAPSHOT

The Asia-Pacific Cancer mTOR Inhibitors market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cancer mTOR Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Afinitor/Votubia
• Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
• Torisel (Temsirolimus)
• Evertor andndash

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Abraxis BioScience
• Adimab
• Celgene Corporation
• Celator Pharmaceuticals
• Eli Lilly
• Exelixis
• GlaxoSmithKline
• HEC Pharm
• Intellikine
• Novartis
• Oneness Biotech
• PIQUR Therapeutics
• Semafore Pharmaceuticals
• Takeda
• Wyeth

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Breast Cancer
• Hematological Malignancy
• Neuroendocrine Tumors
• Hepatocellular Carcinoma
• Glioblastoma

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Cancer mTOR Inhibitors Industry
  1.1.1 Overview
  1.1.2 Development of Cancer mTOR Inhibitors
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Abraxis BioScience (Company Profile, Products & Services, Sales Data etc.)
2.2 Adimab (Company Profile, Products & Services, Sales Data etc.)
2.3 Celgene Corporation (Company Profile, Products & Services, Sales Data etc.)
2.4 Celator Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.5 Eli Lilly (Company Profile, Products & Services, Sales Data etc.)
2.6 Exelixis (Company Profile, Products & Services, Sales Data etc.)
2.7 GlaxoSmithKline (Company Profile, Products & Services, Sales Data etc.)
2.8 HEC Pharm (Company Profile, Products & Services, Sales Data etc.)
2.9 Intellikine (Company Profile, Products & Services, Sales Data etc.)
2.10 Novartis (Company Profile, Products & Services, Sales Data etc.)
2.11 Oneness Biotech (Company Profile, Products & Services, Sales Data etc.)
2.12 PIQUR Therapeutics (Company Profile, Products & Services, Sales Data etc.)
2.13 Semafore Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.14 Takeda (Company Profile, Products & Services, Sales Data etc.)
2.15 Wyeth (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 CANCER MTOR INHIBITORS MARKET BY TYPE

4.1 By Type
  4.1.1 Afinitor/Votubia
  4.1.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
  4.1.3 Torisel (Temsirolimus)
  4.1.4 Evertor andndash
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Breast Cancer
  5.1.2 Demand in Hematological Malignancy
  5.1.3 Demand in Neuroendocrine Tumors
  5.1.4 Demand in Hepatocellular Carcinoma
  5.1.5 Demand in Glioblastoma
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Segment of Cancer mTOR Inhibitors
Table Asia-Pacific Cancer mTOR Inhibitors Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Cancer mTOR Inhibitors
Table Asia-Pacific Cancer mTOR Inhibitors Market 2012-2023, by Application, in USD Million
Table Abraxis BioScience Overview List
Table Cancer mTOR Inhibitors Business Operation of Abraxis BioScience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Adimab Overview List
Table Cancer mTOR Inhibitors Business Operation of Adimab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Cancer mTOR Inhibitors Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celator Pharmaceuticals Overview List
Table Cancer mTOR Inhibitors Business Operation of Celator Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Cancer mTOR Inhibitors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Exelixis Overview List
Table Cancer mTOR Inhibitors Business Operation of Exelixis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Cancer mTOR Inhibitors Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table HEC Pharm Overview List
Table Cancer mTOR Inhibitors Business Operation of HEC Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intellikine Overview List
Table Cancer mTOR Inhibitors Business Operation of Intellikine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis Overview List
Table Cancer mTOR Inhibitors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Oneness Biotech Overview List
Table Cancer mTOR Inhibitors Business Operation of Oneness Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PIQUR Therapeutics Overview List
Table Cancer mTOR Inhibitors Business Operation of PIQUR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Semafore Pharmaceuticals Overview List
Table Cancer mTOR Inhibitors Business Operation of Semafore Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Overview List
Table Cancer mTOR Inhibitors Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Wyeth Overview List
Table Cancer mTOR Inhibitors Business Operation of Wyeth (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Cancer mTOR Inhibitors Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Cancer mTOR Inhibitors Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Cancer mTOR Inhibitors Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Cancer mTOR Inhibitors Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Afinitor/Votubia
Table Major Company List of Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
Table Major Company List of Torisel (Temsirolimus)
Table Major Company List of Evertor andndash
Table Asia-Pacific Cancer mTOR Inhibitors Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Cancer mTOR Inhibitors Market 2012-2017, by Type, in Volume
Table Asia-Pacific Cancer mTOR Inhibitors Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Cancer mTOR Inhibitors Market Forecast 2018-2023, by Type, in Volume
Table Cancer mTOR Inhibitors Demand in Breast Cancer, 2012-2017, in USD Million
Table Cancer mTOR Inhibitors Demand in Breast Cancer, 2012-2017, in Volume
Table Major Consumers in Breast Cancer
Table Cancer mTOR Inhibitors Demand in Hematological Malignancy, 2012-2017, in USD Million
Table Cancer mTOR Inhibitors Demand in Hematological Malignancy, 2012-2017, in Volume
Table Major Consumers in Hematological Malignancy
Table Cancer mTOR Inhibitors Demand in Neuroendocrine Tumors, 2012-2017, in USD Million
Table Cancer mTOR Inhibitors Demand in Neuroendocrine Tumors, 2012-2017, in Volume
Table Major Consumers in Neuroendocrine Tumors
Table Cancer mTOR Inhibitors Demand in Hepatocellular Carcinoma, 2012-2017, in USD Million
Table Cancer mTOR Inhibitors Demand in Hepatocellular Carcinoma, 2012-2017, in Volume
Table Major Consumers in Hepatocellular Carcinoma
Table Cancer mTOR Inhibitors Demand in Glioblastoma, 2012-2017, in USD Million
Table Cancer mTOR Inhibitors Demand in Glioblastoma, 2012-2017, in Volume
Table Major Consumers in Glioblastoma
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Cancer mTOR Inhibitors Demand Forecast 2018-2023, by Application, in USD Million
Table Cancer mTOR Inhibitors Demand Forecast 2018-2023, by Application, in Volume
Table Cancer mTOR Inhibitors Production 2012-2017, by Region, in USD Million
Table Cancer mTOR Inhibitors Production 2012-2017, by Region, in Volume
Table Asia-Pacific Cancer mTOR Inhibitors Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Cancer mTOR Inhibitors Market Size 2012-2017, by Region, in Volume
Table China Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in USD Million
Table China Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in Volume
Table China Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in USD Million
Table China Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in Volume
Table Japan Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in USD Million
Table Japan Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in Volume
Table Japan Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in USD Million
Table Japan Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in Volume
Table India Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in USD Million
Table India Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in Volume
Table India Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in USD Million
Table India Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in Volume
Table India Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in USD Million
Table India Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in Volume
Table Oceania Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in USD Million
Table Oceania Cancer mTOR Inhibitors Market Size 2012-2017, by Country, in Volume
Table Oceania Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in USD Million
Table Oceania Cancer mTOR Inhibitors Market Size 2012-2017, by Type, in Volume
Table Oceania Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in USD Million
Table Oceania Cancer mTOR Inhibitors Market Size 2012-2017, by Application, in Volume
Table Cancer mTOR Inhibitors Market Forecast 2018-2023, by Region, in USD Million
Table Cancer mTOR Inhibitors Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Cancer mTOR Inhibitors

List Of Figures

LIST OF FIGURES

Figure Cancer mTOR Inhibitors Industry Chain Structure
Figure Asia-Pacific Cancer mTOR Inhibitors Market Size and Growth Rate 2012-2023
Figure China Cancer mTOR Inhibitors Market, by Company, in 2018
Figure Japan & Korea Cancer mTOR Inhibitors Market, by Company, in 2018
Figure India Cancer mTOR Inhibitors Market, by Company, in 2018
Figure Southeast Asia Cancer mTOR Inhibitors Market, by Company, in 2018
Figure Oceania Cancer mTOR Inhibitors Market, by Company, in 2018
Figure Asia-Pacific Cancer mTOR Inhibitors Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Cancer mTOR Inhibitors Market Growth 2012-2017, by Type, in Volume
Figure China Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure China Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in Volume
Figure India Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure India Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Oceania Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in USD Million
Figure Oceania Cancer mTOR Inhibitors Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview